ReviewRheumatology international2015
Canakinumab efficacy and long-term tocilizumab administration in tumor necrosis factor receptor-associated periodic syndrome (TRAPS).
Francesco La Torre et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this papercites it